Snyder Mark Drugs Roselle, Inc. dba Mark Drugs Pharmacy

FDA inspection history in Roselle, Illinois, 2017 to 2019

2
Form 483s
1
Close-out

Every document, by year

  • Form 483
  • Close-out

2017: one Form 483; 2018: one close-out letter; 2019: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2017–19Two Form 483s and one close-out letter, at Roselle, Illinois.
  2. 2017The longest 483 on file: 6 observations over 4 pages at Roselle, Illinois.

Cited most

Across all Snyder Mark Drugs Roselle, Inc. dba Mark Drugs Pharmacy observations on file

The complete Snyder Mark Drugs Roselle, Inc. dba Mark Drugs Pharmacy file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2019-09-27483 Form 483$99
2018-02-27Close-out Close-out letter$99
2017-05-22483 Form 483$99

FEI number 3004486825 · most recent document Sep 27, 2019

About Snyder Mark Drugs Roselle, Inc. dba Mark Drugs Pharmacy

How many FDA Form 483s has Snyder Mark Drugs Roselle, Inc. dba Mark Drugs Pharmacy received?

FDA Intel has 2 Form 483s on file for Snyder Mark Drugs Roselle, Inc. dba Mark Drugs Pharmacy; the most recent is dated Sep 27, 2019.

When was Snyder Mark Drugs Roselle, Inc. dba Mark Drugs Pharmacy last inspected by FDA?

The most recent FDA inspection document on file for Snyder Mark Drugs Roselle, Inc. dba Mark Drugs Pharmacy is a Form 483 dated Sep 27, 2019, for the site in Roselle, Illinois.

What did FDA cite at Snyder Mark Drugs Roselle, Inc. dba Mark Drugs Pharmacy?

The regulations cited most in the observations on file for Snyder Mark Drugs Roselle, Inc. dba Mark Drugs Pharmacy are 21 CFR 211.113 (Control of microbiological contamination), 3 times; 21 CFR 211.165 (Testing and release for distribution), 2 times; 21 CFR 211.42 (Design and construction features), 2 times.